Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Metformin and cancer: mounting evidence against an association.

Literature DB >> 24963109

Metformin and cancer: mounting evidence against an association.

Samy Suissa¹, Laurent Azoulay².

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2014 PMID： 24963109 DOI： 10.2337/dc14-0500

Source DB: PubMed Journal: Diabetes Care ISSN： 0149-5992 Impact factor: 19.112

Keyword Cloud
Cited

× No keyword cloud information.

38 in total

1. Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.

Authors: Harvey J Murff; Christianne L Roumie; Robert A Greevy; Amber J Hackstadt; Lucy E D'Agostino McGowan; Adriana M Hung; Carlos G Grijalva; Marie R Griffin
Journal: Cancer Causes Control Date: 2018-07-18 Impact factor: 2.506

2. Association between metformin medication, genetic variation and prostate cancer risk.

Authors: Min Joon Lee; Viranda H Jayalath; Wei Xu; Lin Lu; Stephen J Freedland; Neil E Fleshner; Girish S Kulkarni; Antonio Finelli; Theodorus H van der Kwast; Robert J Hamilton
Journal: Prostate Cancer Prostatic Dis Date: 2020-05-18 Impact factor: 5.554

Review 3. Targeting the translation machinery in cancer.

Authors: Mamatha Bhat; Nathaniel Robichaud; Laura Hulea; Nahum Sonenberg; Jerry Pelletier; Ivan Topisirovic
Journal: Nat Rev Drug Discov Date: 2015-03-06 Impact factor: 84.694

4. Clinical benefits of metformin in gynecologic oncology.

Authors: Atsushi Imai; Satoshi Ichigo; Kazutoshi Matsunami; Hiroshi Takagi; Keigo Yasuda
Journal: Oncol Lett Date: 2015-05-25 Impact factor: 2.967

Review 5. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.

Authors: Jun Gong; Gauri Kelekar; James Shen; John Shen; Sukhpreet Kaur; Monica Mita
Journal: Target Oncol Date: 2016-08 Impact factor: 4.493

6. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.

Authors: Zhihong Gong; Aaron K Aragaki; Rowan T Chlebowski; JoAnn E Manson; Thomas E Rohan; Chu Chen; Mara Z Vitolins; Lesley F Tinker; Erin S LeBlanc; Lewis H Kuller; Lifang Hou; Michael J LaMonte; Juhua Luo; Jean Wactawski-Wende
Journal: Int J Cancer Date: 2015-12-15 Impact factor: 7.396

Metformin and cancer: mounting evidence against an association.

1. Metformin use and incidence cancer risk: evidence for a selective protective effect against liver cancer.

2. Association between metformin medication, genetic variation and prostate cancer risk.

Review 3. Targeting the translation machinery in cancer.

4. Clinical benefits of metformin in gynecologic oncology.

Review 5. The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.

6. Diabetes, metformin and incidence of and death from invasive cancer in postmenopausal women: Results from the women's health initiative.

7. A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival.

8. Predictors of prevalent statin use among older adults identified as statin initiators based on Medicare claims data.

Review 9. Expanding the therapeutic spectrum of metformin: from diabetes to cancer.

Review 10. KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.